Literature DB >> 28958607

Evidenced-Based Cognitive Rehabilitation for Persons With Multiple Sclerosis: An Updated Review of the Literature From 2007 to 2016.

Yael Goverover1, Nancy D Chiaravalloti2, Amanda R O'Brien3, John DeLuca4.   

Abstract

OBJECTIVE: To update the clinical recommendations for cognitive rehabilitation of people with multiple sclerosis (MS), based on a systematic review of the literature from 2007 through 2016. DATA SOURCES: Searches of MEDLINE, PsycINFO, and CINAHL were conducted with a combination of the following terms: attention, awareness, cognition, cognitive, communication, executive, executive function, language, learning, memory, perception, problem solving, reasoning, rehabilitation, remediation, training, processing speed, and working memory. One hundred twenty-nine articles were identified and underwent initial screening. STUDY SELECTION: Fifty-nine articles were selected for inclusion after initial screening. Nineteen studies were excluded after further detailed review. Forty studies were fully reviewed and evaluated. DATA EXTRACTION: Articles were assigned to 1 of 6 categories: attention, learning and memory, processing speed and working memory, executive functioning, metacognition, or nonspecified/combined cognitive domains. Articles were abstracted and levels of evidence were decided using specific criteria. DATA SYNTHESIS: The current review yielded 6 class I studies, 10 class II studies, and 24 class III studies. One intervention in the area of verbal learning and memory received support for a practice standard, 2 computer programs received support as practice guidelines (in the area of attention and multicognitive domains), and several studies provided support for 5 practice options in the domains of attention and learning and memory.
CONCLUSIONS: Substantial progress has been made since our previous review regarding the identification of effective treatments for cognitive impairments in persons with MS. However, much work remains to be done to optimize rehabilitation potential by applying the most methodologically rigorous research designs to provide class I evidence in support of a given treatment strategy.
Copyright © 2017 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition disorders; Cognitive therapy; Multiple sclerosis; Practice guidelines as topic; Rehabilitation; Review [publication type]

Mesh:

Year:  2017        PMID: 28958607     DOI: 10.1016/j.apmr.2017.07.021

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  28 in total

1.  Neurological update: cognitive rehabilitation in multiple sclerosis.

Authors:  Michelle H Chen; Nancy D Chiaravalloti; John DeLuca
Journal:  J Neurol       Date:  2021-05-24       Impact factor: 4.849

2.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

3.  Brief and cost-effective tool for assessing verbal learning in multiple sclerosis: Comparison of the Rey Auditory Verbal Learning Test (RAVLT) to the California Verbal Learning Test - II (CVLT-II).

Authors:  Meghan Beier; Abbey J Hughes; Michael W Williams; Elizabeth S Gromisch
Journal:  J Neurol Sci       Date:  2019-03-19       Impact factor: 3.181

4.  Effectiveness of Three-Dimensional Multiple-Object Tracking in Patients with Multiple Sclerosis: A Pilot Trial.

Authors:  Sebastian Harenberg; Jennifer St Onge; Jill Robinson; Omorowa Eguakun; Anthony Feinstein; Kim Dorsch; Rumit Singh Kakar; Raghig Abdulhakim; Zia Rehman; Melad Shawush; Vinesh Pillay
Journal:  Int J MS Care       Date:  2020-10-16

5.  Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.

Authors:  Dawn W Langdon; Davorka Tomic; Iris-Katharina Penner; Pasquale Calabrese; Gary Cutter; Dieter A Häring; Frank Dahlke; Ludwig Kappos
Journal:  Eur J Neurol       Date:  2021-10-12       Impact factor: 6.288

Review 6.  Clinical Applications of Myelin Plasticity for Remyelinating Therapies in Multiple Sclerosis.

Authors:  Simon Pan; Jonah R Chan
Journal:  Ann Neurol       Date:  2021-08-30       Impact factor: 11.274

7.  Sleep Disturbance and Cognitive Dysfunction in Multiple Sclerosis: a Systematic Review.

Authors:  Abbey J Hughes; Katherine M Dunn; Trisha Chaffee
Journal:  Curr Neurol Neurosci Rep       Date:  2018-01-29       Impact factor: 5.081

8.  Memory in multiple sclerosis: A reappraisal using the item specific deficit approach.

Authors:  Michael R Basso; Douglas Whiteside; Dennis Combs; Steven Paul Woods; Jordan Hoffmeister; Ryan Mulligan; Peter Arnett; Eva Alden; Oliver Tobin
Journal:  Neuropsychology       Date:  2021-02       Impact factor: 3.295

9.  Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.

Authors:  Cristina Fernandez-Carbonell; Leigh E Charvet; Lauren B Krupp
Journal:  Paediatr Drugs       Date:  2021-05-17       Impact factor: 3.022

Review 10.  Treatment and management of cognitive dysfunction in patients with multiple sclerosis.

Authors:  John DeLuca; Nancy D Chiaravalloti; Brian M Sandroff
Journal:  Nat Rev Neurol       Date:  2020-05-05       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.